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Abstract 
 
Background: Stellate ganglion nerve activity (SGNA) is important in cardiac arrhythmogenesis. 
However, direct recording of SGNA requires access to the thoracic cavity. Skin of upper thorax 
is innervated by sympathetic nerve fibers originating from the stellate ganglia (SG) and is easily 
accessible. 
Objective: To test the hypothesis that thoracic skin nerve activity (SKNA) can be used to 
estimate SGNA.  
Methods: We recorded SGNA and SKNAs using surface electrocardiogram leads in 5 
anesthetized and 4 ambulatory dogs. Apamin injected into the right SG abruptly increased both 
right SGNA and SKNA in 5 anesthetized dogs. We integrated nerve activities and averaged 
heart rate in each one-min window over 10 min. We implanted a radiotransmitter to record left 
SGNA in 4 ambulatory dogs, including two normal dogs, one dog with myocardial infarction and 
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one dog with intermittent rapid atrial pacing. After 2 weeks of recovery, we simultaneously 
recorded the SKNA and left SGNA continuously for 30 min when the dogs were ambulatory. 
Results: There was a positive correlation (average r=0.877, 95% confidence interval (CI) 0.732 
to 1.000, p<0.05 for each dog) between integrated SKNA (iSKNA) and SGNA (iSGNA) and 
between iSKNA and heart rate (average r=0.837, 95% CI 0.752 to 0.923, p<0.05). Similar to 
that found in the anesthetized dogs, there was a positive correlation (average r=0.746, 95% CI 
0.527 to 0.964, p<0.05) between iSKNA and iSGNA and between iSKNA and heart rate 
(average r=0.706, 95% CI 0.484 to 0.927, p<0.05). 
Conclusions: SKNAs can be used to estimate SGNA in dogs.  
 
Key Words: autonomic nervous system; sympathetic nerve; stellate ganglion; cardiac 
arrhythmia 
 
Abbreviations: CI = confidence interval; DSI = Data Sciences International; ECG = 
electrocardiogram; EMG = electromyogram; FFT = fast Fourier transform; HR = heart rate; 
SCNA = subcutaneous nerve activity; SG = stellate ganglia; SGNA = stellate ganglion nerve 
activity; SK = small conductance calcium activated K; SKNA = skin nerve activity 
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Introduction 
Sympathetic tone is important in cardiac arrhythmogenesis.1 Previous studies have shown that 
directly recorded stellate ganglion nerve activity (SGNA) immediately precedes heart rate 
acceleration and spontaneous cardiac arrhythmias in ambulatory dogs,1  suggesting that SGNA 
may be useful in cardiac arrhythmia prediction and risk stratification. Because direct recording 
from the stellate ganglion requires thoracotomy, it is difficult to record SGNA from humans. The 
skin of the canine upper thorax is extensively innervated by sympathetic nerves from the stellate 
ganglion.2 We3 recently reported that subcutaneous nerve activity (SCNA) recorded by bipolar 
subcutaneous electrodes in the thorax correlated well with the SGNA and heart rate in 
ambulatory dogs. Therefore, SCNA can be used to estimate the sympathetic tone. However, a 
skin incision is still needed for implanting the subcutaneous electrodes. For clinical applications 
for cardiovascular risk stratification, it is highly desirable to develop a completely non-invasive 
method for direct skin sympathetic nerve activity recording. We hypothesize that it is possible to 
record skin nerve activity (SKNA) from the surface of the skin in dogs, and that the SKNA 
recorded from the upper chest wall can be used to estimate the SGNA. The purpose of the 
present study was to develop a method for SKNA recording and to compare the SKNA with 
SGNA and with heart rate. The results were used to test the hypothesis that SKNA can be used 
to estimate SGNA in both anesthetized and ambulatory dogs. 
 
Methods 
The animal protocol was approved by the Institutional Animal Care and Use Committee of the 
Indiana University School of Medicine and the Methodist Research Institute, Indianapolis, IN, 
and conformed to the Guide for Care and Use of Laboratory Animals. A total of 9 dogs were 
studied. 
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Protocol 1: Right SGNA and SKNA in anesthetized dogs 
Five dogs (A, B, C, D, E) were used in this protocol. The first two dogs were also used for SCNA 
recording and those results were included in a previous report.3 The dogs were intubated and 
underwent isoflurane general anesthesia. Thoracotomy was performed through the right 3rd 
intercostal space and the hair on the thoracic skin was removed. A pair of bipolar electrodes 
was inserted under the fascia of the right stellate ganglion. Another pair of bipolar electrodes 
with the interelectrode distance of 4 cm was inserted into the subcutaneous tissues of the right 
3rd intercostal space for SCNA recording. Electrocardiogram (ECG) patches (Tyco/Healthcare 
Kendall, Medi-Trace 100, Hampshire, U.K.) were secured on the skin using adhesive tapes for 
surface ECG and SKNA recording. Two pairs of those ECG patch electrodes were taped on the 
skin to record ECG Leads I and II, along with SKNA. Lead I was recorded between electrodes at 
the level of the 2nd rib with an interelectrode distance of 22 cm (Figure 1A). Lead II was recorded 
between electrodes on right second rib and the left lower abdomen, with an interelectrode 
distance of 48 cm (Figure 1A). An additional patch was secured to the right lower abdomen to 
serve as ground. 
    To explore whether or not other locations on the chest wall can also be used for SKNA 
recording, we placed one pair of bipolar electrodes each at the level of the right and left 3rd rib in 
dogs B and C, respectively, to form bipolar electrodes with 12 cm interelectrode distance 
(Figures 1B and 1C). In dogs D and E, we moved these bipolar electrodes downwards to the 
lower 1/3rd of the chest to determine if SKNA from the lower chest can also be used for 
recording sympathetic nerve activity. These electrodes were connected to a World Precision 
Instrument Iso-Damm-8 amplifier (Sarasota, Florida), with a noise level of < ±2.5 µV and a 
recording bandwidth set at 10 Hz-3 KHz. The signals were digitized by Digidata 1400a using 
AxoScope software (Sunnyvale, Calif) at 10,000 times per second per channel. After all surgical 
procedures were performed, the anesthetic agents were switched from isoflurane to alpha-
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chloralose (up to 100 mg/kg) and morphine. We then injected 1 ml apamin (concentration 0.2 
ng/μL) directly into the right stellate ganglion. Apamin, a neurotoxin, is a specific blocker of the 
small conductance calcium activated K (SK) channel.4 Inhibition of the SK channel is known to 
facilitate neuronal discharges.3, 5 Data were acquired for 10 min after apamin injection.  
 
Protocol 2: Left SGNA and SKNA in ambulatory dogs 
Four dogs (F, G, H, I) were used in this protocol. All four dogs were chronically instrumented for 
different research protocols. The non-invasive recording made in this study does not affect the 
results of those research protocols, but helps reduce the use of animals. The dogs underwent 
left thoracotomy through the third intercostal space. A DSI (Data Sciences International, St. Paul, 
MN) D70EEE radiotransmitter was implanted to record the left SGNA (LSGNA) and the 
subcutaneous ECG according to methods reported elsewhere.3 Dogs F and G were normal 
dogs and did not undergo other procedures. Dog H had undergone left thoracotomy and left 
circumflex coronary artery ligation to create myocardial infarction. These dogs were allowed to 
recover for 2 weeks after the initial surgery before they were studied. Dog I had undergone a 
modified Secura implantable cardioverter-defibrillator (Medtronic, Minneapolis, MN) implantation 
for intermittent rapid left atrial pacing in an attempt to induce paroxysmal AF according to 
methods reported elsewhere.6 That dog was allowed to recover for 2 weeks from surgery, and 
was then paced intermittently for 8 weeks. However, it was in sinus rhythm when used in the 
present study. At the time of the study, all wounds had healed and the dogs were ambulatory. 
After clipping the hair on the chest, we placed 4 ECG patches on the skin to record surface 
ECG Leads I and II according to the methods described in Protocol 1. An additional two pairs of 
bipolar electrodes were placed on the upper 1/3rd of the left and right thorax for bipolar ECG 
recordings. Soft, non-adhesive elastic bands were wrapped around the chest to help secure the 
ECG patches in place. The locations of surface ECG patch electrodes were the same as shown 
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in Figure 1. These skin electrodes were connected to the same equipment as described in 
Protocol 1. A DSI RLA3000 Mini "wand" Receiver was used to transmit the signals from the 
implanted DSI D70EEE radiotransmitter to the same Digidata 1400a equipment. The data from 
skin and the D70EEE were digitized simultaneously at 10,000 times per s per channel (same as 
in Protocol 1). Continuous recordings were made for 30 min while the dog was awake and lying 
or standing in the dog run. Hand clapping and speaking among the investigators were used to 
encourage sympathetic nerve discharges. 
 
Data Analysis 
We analyzed recordings using custom written DSIView software. The same ECG signals were 
used for both SKNA and ECG analyses. We performed quantitative analyses by integrating 
SGNA (iSGNA), SKNA (iSKNA), SCNA (iSCNA) min by min. In Protocol 1, the signals of SKNA-
I were low-pass filtered at 100 Hz to display the surface ECG for heart rate analyses. The 
signals of SKNA-I, SCNA and that of right SGNA (RSGNA) were either high-pass filtered (at 150 
Hz, 300 Hz, 500Hz or 700 Hz) or wavelet filtered7 to display nerve activities. The wavelet 
transform7 is a time–frequency analysis and signal coding tool favored for the interrogation of 
complex non-stationary signals. In our application, we used discrete wavelet filtering based on a 
standard wavelet (Daubechies wavelet, db06) to remove the ECG, and kept the remnant 
aperiodic, non-stationary components to represent the nerve activities. In addition, fast Fourier 
transform (FFT) integration analyses were used to analyze the correlation between SKNA-I and 
RSGNA with the integrated magnitude spectrum between 200 Hz – 1000 Hz from a 2-s 
recording. In Protocol 2, the signals of SKNA-I, SCNA and LSGNA were high-pass filtered at 
150 Hz or wavelet filtered to display the nerve activity. The same signals of SKNA-I was also 
low-pass filtered at 100 Hz to display ECG for heart rate analyses. The data were reported as 
mean and 95% confidence interval (CI). Pearson correlation coefficients were calculated 
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between heart rate, iSGNA, iSCNA and iSKNA. A p value of ≤0.05 was considered statistically 
significant. 
 
Results 
 
Protocol 1: Correlation between iSGNA and iSKNA after apamin injection 
Apamin injection induced robust activity of SKNA and SGNA in all dogs studied. Figure 2A 
shows a typical recording from Dog D. Apamin-induced SGNA, SKNA and heart rate 
acceleration. Figure 2B shows the relationship among integrated right SGNA (iRSGNA), 
integrated SKNA recorded by ECG Lead I (iSKNA-I), ECG Lead II (iSKNA-II), right chest 
(iSKNA-R), left chest (iSKNA-L) and heart rate of the same dog. All of them strongly correlated 
with each other.   
 
Protocol 2: Monitoring of spontaneous SKNA, SGNA and heart rate in Ambulatory Dogs 
Simultaneous recording of SGNA and SKNAs was successful in all dogs studied. There were 
electrical signals resembling nerve activities on the surface of skin. During the recording period, 
the sound created by the investigators (speaking and clapping of the hands) or barking of other 
dogs in the same room often caused abrupt activation of the SGNA. Figure 3A shows a typical 
recording from dog I. The SGNA was associated with elevated heart rate and the SKNA at all 
locations. The arrow shows that largest heart rate acceleration associated with largest LSGNA 
and SKNA recordings. Figure 3B shows significantly positive correlations among integrated left 
SGNA (iLSGNA) and iSKNA-I, iSKNA-II, iSKNA-R, iSKNA-L and heart rate.  
 
Table 1 shows the correlation coefficients and the p values of all dogs studied. As shown in this 
table, there is consistently a strong positive correlation (mean 0.877) found between iSGNA and 
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iSKNA-I in all dogs of Protocol 1. A good correlation (mean 0.746) was found between iSGNA 
and iSKNA-I in Protocol 2. Both right and left integrated SGNA (iRSGNA and iLSGNA) 
correlated well with the ipsilateral integrated SKNA (iSKNA-R and iSKNA-L) respectively.  All 
other correlations were positive and mostly statistically significant.  
  
Correlation between iSGNA and iSKNA using FFT integration analyses 
As shown in Figure 4, changes in the frequency content from the RSGNA recordings correlates 
to changes in the frequency content from the SKNA-I recordings in all dogs of Protocol 1. The 
correlation coefficients (mean 0.729, 95% CI 0.615 to 0.843) were significant (p<0.05) for all 
dogs studied.  
 
Wavelet filtering and different frequencies of high-pass filter settings 
We applied wavelet filtering to the same data shown in Figure 3. As shown in Figure 5A, 
wavelet filtering successfully removed the ECG artifacts but preserved the patterns of nerve 
activities. Figure 5B shows significant and positive correlations among filtered nerve activities 
and heart rate. Table 2 shows the correlation between iSKNA-I and iRSGNA, iSCNA or heart 
rate at different high pass filter settings. There were significant correlations between iSKNA-I 
and iRSGNA, between iSKNA and iSCNA and between iSKNA and heart rate at different high-
pass filter settings. Table 3 shows the same correlations after the signals were filtered by the 
wavelet filter. The correlations were significant and positive for all dogs studied.  
 
Discussion 
 
The main novel finding is that it is feasible to record sympathetic nerve activities from the 
surface of the skin. This method is completely non-invasive, thus can facilitate the clinical 
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studies of cardiac sympathetic tone in humans. We also found that among the nerve activities 
registered from all recording leads, the SKNA-I most accurately estimated the SGNA. 
 
Correlation between SKNA and SGNA 
Stellate (cervicothoracic) ganglion is a sympathetic ganglion formed by the fusion of the inferior 
cervical ganglion and the first thoracic ganglion, and is known to be an important source of 
cardiac sympathetic innervation.8 Extensive clinical studies have shown that the left stellate 
ganglion is important in cardiac arrhythmogenesis, and that left stellate ganglion ablation is 
antiarrhythmic in patients with cardiac arrhythmias.9-12 Our previous studies have documented a 
direct relationship between SGNA and cardiac arrhythmias in ambulatory dogs.6, 13-15 In addition 
to being major sources of cardiac sympathetic innervation, stellate ganglia also gives rise to 
sympathetic nerves that innervate blood vessels and sweat glands in skin.2 We3 have recently 
showed that it is feasible to record SCNA from ambulatory dogs continuously over long periods 
of time. We extended the latter observations in the present study by documenting the feasibility 
of directly recording sympathetic nerve activities from the surface of the skin, and that SKNA 
correlated well with SGNA and SCNA. Because SCNA can be used to predict susceptibility to 
ventricular tachycardia and fibrillation in a canine model of ventricular arrhythmia and sudden 
cardiac death,16 it is possible that SKNA can also be used for that arrhythmia prediction and risk 
stratification. 
 
Methods of signal filtering 
The electrical signals on the skin can come from multiple different sources, including the heart, 
the skeletal muscle, the subcutaneous nerves and the motion artifacts. Therefore, the high pass 
filter setting may play an important role in determining the sensitivity and specificity of the SKNA 
recordings. A major source of electrical signal on the skin is ECG, which has frequencies below 
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150 Hz. That frequency was used as the standard low pass filter setting for ECG recordings.3 A 
second important source of electrical signal is the skeletal muscle activity. McAuley et al17 
reviewed and summarized approximately 30 published reports on electromyogram (EMG) 
frequency distribution during muscle vibration and tremor in distal limb of healthy subjects. They 
found that the frequency peaks are always < 100 Hz. Most of the muscle activities are 
associated with much lower frequency (between 10 and 50 Hz).  Komi and Tesch18 studied the 
EMG of 11 male physical education students using equipment that has a frequency range of 10 
to 10,000 Hz. They found that EMG of non-fatigued muscle peaked at < 100 Hz, with small 
amount of the activities reaching nearly 400 Hz. The fatigued muscles generate much narrower 
frequency spectrum and does not typically reach 200 Hz. The vibration of muscle spindles can 
reach 200 Hz.19 A high pass filtering of >150 Hz eliminates most of the ECG and EMG signals, 
thus increases the specificity of SKNA. However, it also eliminates some real nerve signals that 
have frequencies below 150 Hz.20 Further increases of the high pass filter setting will further 
increase the specificity but in the meantime reduce the sensitivity of SKNA recordings. In the 
present study, we tested multiple different high pass filter settings including that of 700 Hz, 
which is typically used for microneurography studies.21 We found significant correlations 
between SKNA and SGNA at all high pass filter settings. These findings suggest that 150 Hz 
high pass filter setting may have sufficient sensitivity and specificity in recording SKNA. An 
alternative method of filtering the signal is to use the wavelet filter. We showed that using this 
alternative filtering method, significant correlations are maintained among nerve activities and 
heart rate in all dogs studied.  
 
SKNA-I may be the best surrogate for SGNA 
In addition to filter setting, the location of the recording electrodes may be important in detecting 
the SKNA. We implanted four pairs of bipolar electrodes (leads I, II, right and left) on the surface 
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of the skin to record SKNAs. All dogs (9/9) showed a significant correlation between iSKNA-I 
and iRSGNA or iLSGNA. Eight (8/9) dogs showed a strong correlation between iSKNA-II and 
iRSGNA or iLSGNA. Seven (7/8) dogs showed a good correlation between iSKNA-R or iSKNA-
L and iRSGNA or iLSGNA. All dogs (9/9) showed a significant correlation between iSKNA-I and 
heart rate. Seven dogs (7/9) showed a strong correlation between iSKNA-II and heart rate. Five 
(5/8) dogs showed a good correlation between iSKNA-R and heart rate and three (3/8) dogs 
showed a good correlation between iSKNA-L and heart rate. These data suggest that SKNA-I 
may be the best recording lead to estimate the SGNA and the cardiac sympathetic tone. A good 
correlation between iSGNA and ipsilateral iSKNA is compatible with the finding that the skin 
sympathetic innervation came from ipsilateral stellate ganglion.22 However, because the left and 
right stellate ganglia in dogs usually fires simultaneously,23 it is not surprising to see that the 
integrated SKNA recorded from any location on the chest correlated positively with both right 
and left SGNA. 
 
Clinical Implications 
Our results support the feasibility of simultaneous recording the ECG and SKNA from the skin 
surface using the same ECG patch electrodes. The same signals are low-pass filtered for ECG 
signals and high-pass or wavelet filtered for SKNA signals. These techniques may be useful in 
non-invasive clinical investigations of sympathetic tone in humans.  
 
Limitations 
The correlations between SGNA and SKNA for all combinations appear to be stronger in 
Protocol 1 than Protocol 2. A possible explanation is that the equipment used to record SGNA in 
Protocol 1 had much higher frequency bandwidth than D70EEE transmitter used in Protocol 2. 
The D70EEE radiotransmitters are adequate in recording the large nerve discharges associated 
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with the abrupt onset of sinus tachycardia or other atrial tachyarrhythmias, but often miss the 
smaller changes of nerve discharges associated with transient shortening of RR interval.15 The 
weaker correlation is likely the result of insufficient frequency content of the D70EEE, which 
reduced the sensitivity in detecting nerve signals.  
 
Conclusions: It is feasible to record sympathetic nerve activities from the surface of skin. 
SKNAs can be used to estimate SGNA in dogs.  
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Clinical Perspectives 
Sympathetic nerve activity is a critical modulator of cardiovascular function. Studies in 
ambulatory animals showed that stellate ganglion nerve activity (SGNA) is important in cardiac 
arrhythmogenesis. In this manuscript, we disclose a novel method for direct measurement of 
sympathetic nerve activity by recording skin nerve activity (SKNA) using standard ECG 
electrodes. The SKNA and ECG can be recorded simultaneously from the skin surface using 
the same ECG patch electrodes. SKNA recorded from the Lead I ECG and from other bipolar 
surface ECG leads can be used to estimate the SGNA and cardiac sympathetic tone. Direct 
recording of SGNA requires access to the thoracic cavity. Therefore, it is difficult to directly 
record SGNA in human subjects. In our recent study, we have found that subcutaneous nerve 
activity (SCNA) can be used to estimate the sympathetic tone and SGNA. However, a skin 
incision or puncture is still needed for implanting the subcutaneous electrodes. The methods of 
SKNA recording are non-invasive, thus can be easily translated to humans. Before the 
discoveries are translated into clinical practice, the equipment used to record SKNA should be 
improved. A portable and convenient device is needed for long-term and continuous SKNA 
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recording. In addition, clinical trials should be performed to verify the relationship between 
SKNA and cardiac arrhythmogenesis in humans. The results of the latter studies will help 
determine how much information SKNA adds beyond the heart rate (or heart rate variability) in 
estimating the sympathetic tone. 
 
Figure 1. Schematics of electrode location on the surface of the skin showing dogs in supine 
(A), left decubitus (B) and right decubitus (C) positions. In A, the two electrodes for Lead I 
recording were placed on the second rib and were 22 cm apart (11 cm from the midline). The 
Lead II electrodes were separated by 48 cm. B shows the location of the right bipolar electrode 
pair for recording SKNA-R. C shows the location of the left bipolar electrode pair for recording 
SKNA-L. 
Figure 2. Apamin increases nerve activities and heart rate (Protocol 1). A shows the actual 
recording made in Dog D after apamin injection, showing elevated heart rate (HR), along with 
the elevation of right stellate ganglion nerve activity (RSGNA), skin nerve activity from Lead-I 
(SKNA-I), skin nerve activity from Lead II (SKNA-II), skin nerve activity from right chest bipolar 
lead (SKNA-R) and left chest bipolar lead (SKNA-L). The ECG was from the same recording 
obtained from SKNA-I, but low pass filtered at 100 Hz. B shows correlation between integrated 
nerve activities recorded from different locations, and between integrated nerve activities and 
heart rate. Each filled circle represents the average of nerve activity and heart rate over a one-
min window. A positive correlation was found in each comparison, but 3 of them (iRSGNA vs 
iSKNA-L, HR vs iSKNA-R and HR vs iSKNA-L) were statistically insignificant. The strongest 
correlation was found between iRSGNA and iSKNA- I, followed by the correlation between HR 
with iRSGNA and between HR and iSKNA-I. 
Figure 3. SKNA in ambulatory dogs (Protocol 2). The recording came from Dog I. The LSGNA 
was recorded by DSI D70EEE radiotransmitter, while the remaining nerve activities and ECG 
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were recorded by the Iso-Damm-8 amplifier. All data were then digitized simultaneously by 
Digidata 1400a. A shows increased LSGNA activity was associated with increased SKNA and 
heart rate (arrows). B shows positive correlations among the nerve activities and the heart rate. 
The p values of all correlations were < 0.05. The best correlation was that between iLSGNA and 
iSKNA-L. 
Figure 4. Correlation between integrated SKNA and integrated right SGNA (RSGNA) using FFT 
integration analyses (Protocol 1). Each dot represents the integrated magnitude spectrum 
between 200 Hz – 1000 Hz from the resulting FFT calculated from a 2-s recording.  
Figure 5. SKNA with wavelet filter in ambulatory dog I (same raw data as that used in Figure 3). 
Panel A shows the nerve activities after wavelet filtering. Note the elimination of the surface 
ECG artifacts by wavelet filtering. Panel B shows the correlations among nerve activities and 
heart rate (HR). Significant and positive correlations are present. 
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Table 1.  Correlations among nerve activities measured at different sites and the heart 
rate  
 
Protocol 1. 
Dog# 
iRSGNA 
vs. 
iSKNA-Ⅰ 
iRSGNA 
vs. 
iSKNA-Ⅱ 
iRSGNA 
vs. 
iSKNA-R 
iRSGNA 
vs. 
iSKNA-L 
HR vs. 
iRSGNA  
HR vs. 
iSKNA-Ⅰ 
HR vs. 
iSKNA-Ⅱ 
HR vs. 
iSKNA-R 
HR vs. 
iSKNA-L 
A 
r = 0.948 
p <0.001 
0.933 
<0.001 
NA NA 0.834 
0.005 
0.886 
0.001 
0.859 
0.003 
NA NA 
B 
r = 0.749  
p =0.020 
0.729 
0.026 
0.864 
0.003 
0.715 
0.031 
0.875 
0.002 
0.823 
0.006 
0.907 
0.001 
0.725 
0.027 
0.586 
0.097 
C 
r = 0.985 
p <0.001  
0.881 
0.002 
0.951 
<0.001 
0.885 
0.002 
0.867 
0.002 
0.783 
0.013 
0.933 
<0.001 
0.600 
0.088 
0.583 
0.099 
D 
r = 0.950 
p <0.001 
0.773 
0.014 
0.748 
0.020 
0.564 
0.114 
0.926 
<0.001 
0.929 
<0.001 
0.715 
0.030 
0.551 
0.125 
0.539 
0.135 
E 
r = 0.751 
p =0.020 
0.603 
0.086 
0.802 
0.009 
0.772 
0.015 
0.881 
0.002 
0.766 
0.016 
0.548 
0.126 
0.453 
0.221 
0.507 
0.163 
Mean 0.877 0.784 0.841 0.734 0.877 0.837 0.792 0.582 0.554 
95%CI 
(0.732, 
1.000) 
(0.622, 
0.945) 
(0.703, 
0.980) 
(0.521, 
0.947) 
(0.836, 
0.918) 
(0.752, 
0.923) 
(0.593, 
0.992) 
(0.402, 
0.762) 
(0.494, 
0.614) 
Protocol 2 
Dog# 
iLSGNA 
vs. 
iSKNA-Ⅰ 
iLSGNA 
vs. 
iSKNA-Ⅱ 
iLSGNA 
vs. 
iSKNA-R 
iLSGNA 
vs. 
iSKNA-L 
HR vs. 
iLSGNA  
HR vs. 
iSKNA-Ⅰ 
HR vs. 
iSKNA-Ⅱ 
HR vs. 
iSKNA-R 
HR vs. 
iSKNA-L 
F 
r = 0.820 
p <0.001 
0.607 
0.002 
0.728  
<0.001 
0.788 
<0.001 
0.647 
0.001 
0.801 
<0.001 
0.537 
0.008 
0.809 
<0.001 
0.769 
<0.001 
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G 
 r = 0.803 
 p <0.001 
0.604 
0.013 
0.510 
0.018 
0.463 
0.035 
0.591 
0.016 
0.499 
0.049  
0.482 
0.059 
0.510 
0.018 
0.463 
0.035 
H 
 r = 0.540 
 p =0.025 
0.546 
0.023 
0.339 
0.123 
0.506 
0.016 
0.421 
0.093 
0.759 
<0.001 
0.789 
<0.001 
0.644 
0.001 
0.352 
0.108 
I 
 r = 0.819 
 p <0.001 
0.772 
<0.001 
0.760 
<0.001 
0.912 
<0.001 
0.574 
0.001 
0.763 
<0.001 
0.776 
<0.001 
0.749 
<0.001 
0.627 
<0.001 
Mean   0.746 0.632 0.584 0.667 0.558 0.706 0.646 0.678 0.553 
95%CI 
(0.527, 
0.964) 
(0.477, 
0.787) 
(0.270, 
0.899) 
(0.321, 
1.000) 
(0.404, 
0.712) 
(0.484, 
0.927) 
(0.393, 
0.899) 
(0.469, 
0.887) 
(0.261, 
0.844) 
 
HR, heart rate; NA, not available. 
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Table 2.  Correlations with iSKNA-I using different high-pass filter settings in Protocol 1 
 iRSGNA  iRSGNA  iRSGNA iRSGNA iSCNA iSCNA iSCNA iSCNA HR  HR  HR HR 
Dog# 700HZ 500HZ 300HZ 150HZ 700HZ 500HZ 300HZ 150HZ 700HZ 500HZ 300HZ 150HZ 
A 
r = 0.948 
p <0.001 
0.842 
0.002 
0.875 
0.001 
0.673 
0.033  
0.842 
0.002 
0.985 
<0.001 
0.927 
<0.001 
0.825 
0.003 
0.886 
0.001 
0.742 
0.014 
0.825 
0.003 
0.894 
<0.001 
B 
r = 0.749  
p =0.020 
0.875 
0.002 
0.659 
0.038 
0.800 
0.010 
0.735 
0.024 
0.869 
0.002 
0.918 
<0.001 
0.916 
0.001 
0.823 
0.006 
0.744 
0.022 
0.639 
0.046 
0.672 
0.047 
C 
r = 0.985 
p <0.001  
0.992 
<0.001 
0.948 
<0.001 
0.676 
0.046 
0.717 
0.030 
0.838 
0.005 
0.977 
<0.001 
0.850 
0.004 
0.783 
0.013 
0.670 
0.048 
0.774 
0.009 
0.756 
0.018 
D 
r = 0.950 
p <0.001 
0.928 
<0.001 
0.960 
<0.001 
0.933 
<0.001 
0.683 
0.042 
0.684 
0.042 
0.767 
0.016 
0.709 
0.032 
0.929 
<0.001 
0.904 
0.001 
0.931 
<0.001 
0.917 
0.001 
E 
r = 0.751 
p =0.020 
0.948 
<0.001 
0.862 
0.003 
0.898 
0.001 
0.711 
0.032 
0.750 
0.020 
0.759 
0.018 
0.733 
0.025 
0.766 
0.016 
0.716 
0.030 
0.749 
0.020 
0.673 
0.047 
Mean 0.877 0.917 0.861 0.796 0.738 0.825 0.870 0.807 0.837 0.755 0.784 0.782 
95%CI 
(0.732, 
1.000) 
(0.843, 
0.990) 
(0.711, 
1.000) 
(0.646, 
0.946) 
(0.662, 
0.814) 
(0.682, 
0.968) 
(0.746, 
0.994) 
(0.701, 
0.913) 
(0.752, 
0.923) 
(0.645, 
0.865) 
(0.651, 
0.916) 
(0.636, 
0.929) 
 
HR, heart rate 
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Table 3. Correlations with iSKNA-I using wavelet filter. 
 Protocol 1   Protocol 2   
Dog# iRSGNA iSCNA HR Dog# iLSGNA iSCNA HR 
A 
r = 0.637 
p =0.047 
0.855 
0.002 
0.692 
0.027 
F 
r = 0.609 
p <0.001 
0.505 
0.014  
0.693 
<0.001 
B 
r = 0.703  
p =0.030 
0.697 
0.037 
0.784 
0.012 
G 
r = 0.569 
p = 0.021 
0.581 
0.003 
0.516 
0.041 
C 
r = 0.733 
p =0.025  
0.700 
0.036 
0.785 
0.012 
H 
r = 0.455 
p = 0.034 
0.868 
<0.001 
0.732 
<0.001 
D 
r = 0.817 
p =0.007 
0.697 
0.037 
0.850 
0.004 
I 
r = 0.598 
p = 0.001 
0.744  
<0.001 
0.782 
<0.001 
E 
r = 0.909 
p =0.001 
0.783 
0.013 
0.706 
0.034 
   
 
Mean 0.760 0.746 0.763        0.558 0.675      0.681 
95%CI 
(0.629, 
0.891) 
(0.658, 
0.835) 
(0.683, 
0.844) 
       (0.445,   
        0.670) 
(0.415, 
0.934) 
 
 
(0.497, 
0.865) 
 
CI, confidence interval; HR, heart rate 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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Figure 4. 
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Figure 5. 
 
 
 
